CD8A and neoplasm: CD8α+/XCR1+ cDC1 was found to fail in cross-presenting to CD8+ T cells and tumor rejection in the absence of WDFY4 gene, but these mice had normal lymphoid and non-lymphoid cDC1 populations compared to BATF3-deficient mice [41].